Pathological features and prognosis of different molecular subtypes of breast cancer

Molecular Medicine Reports

Volumn 6, Issue 4, 2012, Pages 779-782

  Wang, Guo Sheng ^a   Zhu, Hong ^a   Bi, Shi Jie ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; Pathological features; Prognosis

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; HORMONE RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CANCER; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURGERY; CANCER TISSUE; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FEMALE; GENE OVEREXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MASTECTOMY; MEDICAL RECORD REVIEW; MOLECULAR PATHOLOGY; MOLECULAR TYPING; OVERALL SURVIVAL; PROTEIN EXPRESSION; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETROSPECTIVE STUDIES;

EID: 84865174150     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2012.981     Document Type: Article

References (15)

1. Perou CM, Sødie T, Eisen MB, et al: Molecular portraits of human breast tumours. Nature 406: 747-752, 2000.
2. Holm K, Hegardt C, Staaf J, Vallon-Christersson J, Jönsson G, Olsson H, Borg A and Ringnér M: Molecular subtypes of breast cancer are associated with characteristic DNA methylation pattern. Breast Cancer Res 12: R36, 2010.
3. Maambo EC and Ioffe OB: Molecular classification and prognostication of breast cancer. Pathol Case Rev 14: 129-134, 2009.
4. Kao KJ, Chang KM, Hsu HC and Huang AT: Correlation of microarray-based breast cancer molecular subtypes and clinical outcomes: implications for treatment optimization. BMC Cancer 11: 143, 2011.
5. Carey LA, Pemu CM, Livasy CA, et al: Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295: 2492-2502, 2006. (Pubitemid 43854964)
6. Ihemelandu CU, Leffall LD Jr, Dewitty RL, et al: Molecular breast cancer subtypes in premenopausal and postmenopausal African-American women, age-specific prevalence and survival. J Stag Res 143: 109-118, 2007. (Pubitemid 47562451)
7. Strehl JD, Wachter DL, Fasching PA, Beckmann MW and Hartmann A: Invasive breast cancer: recognition of molecular subtypes. Breast Care (Basel) 6: 258-264, 2011.
8. Prat A, Parker JS, Karginova O, Fan C, Livasy C, Herschkowitz JI, He X and Perou CM: Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res 12: R68, 2010.
9. Chandran U, Hirshfield KM and Bandera EV: The role of anthropometric and nutritional factors on breast cancer risk in African-American women. Public Health Nutr 29: 1-11, 2011.
10. Parker JS, Mullins M, Cheang MC, et al: Supervised risk predictor of breast cancer on intrinsic subtypes. J Clin Oncol 27: 1160-1167, 2009.
11. Voduc KD, Cheang MC, Tyldesley S, Gelmon K, Nielsen TO and Kennecke H: Breast cancer subtypes and the risk of local and regional relapse. J Clin Oncol 28: 1684-1691, 2010.
12. Lund MJ, Trivers KF, Porter PL, et al: Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA. Breast Cancer Res Treat 113: 357-370, 2009.
13. Brinton LA, Sherman ME, Carreon JD and Anderson WF: Recent trends in breast cancer among younger women in the United States. J Natl Cancer Inst 100: 1643-1648, 2008.
14. Carey LA, Dees EC, Sawyer L, et al: The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes. Clin Cancer Res 13: 2329-2334, 2007. (Pubitemid 46698581)
15. Reis-Filho JS and Pusztai L: Gene expression profiling in breast cancer: classification, prognostication, and prediction. Lancet 378: 1812-1823, 2011.